Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 33Pancreatic Neoplasms 14Neuroblastoma 13Neoplasm Metastasis 10Stomach Neoplasms 9Neoplasms 8Rectal Neoplasms 5Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Ovarian Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Wilms Tumor 2Sarcoma 2Recurrence 2Osteosarcoma 2Gastrointestinal Neoplasms 2Ganglioneuroblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Solid Tumors 1

Interventions

S 1 (combination) 1Oxaliplatin 1Mass Screening 1Leucovorin 1Irinotecan 1Hematologic Tests 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pancreatic cancer, adult × Irinotecan × Clear all
NCT03977233 2026-01-13

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
45 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡